Amarin Corp Plcuk (AMRN) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Amarin Corp Plcuk reported revenue of $213.6M, up 4.4% from $204.6M the year before. Net income was -$38.8M (a -18.2% net margin), or -$0.09 per diluted share. Gross margin was 56.6% and operating margin was -23.5%. Operating activities generated $6.7M of cash. At fiscal year end, Amarin Corp Plcuk held $670.8M in total assets against $211.5M in total liabilities, including $134.7M of cash and equivalents.
Open the full interactive Amarin Corp Plcuk financials → Quarterly statements, key ratios, valuation history and price charts.
Amarin Corp Plcuk Key Stats
| Share Price | $11.58 |
|---|---|
| Market Cap | $241.1M |
| Revenue YoY Growth | +4.4% |
| 52-Week Range | $11.53 – $20.25 |
| Shares Outstanding | 416.4 million (basic, 2026 Q2) |
Amarin Corp Plcuk Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $614.1M | $583.2M | $369.2M | $285.3M | $204.6M | $213.6M |
| Cost of Goods Sold | $131.4M | $121.3M | — | — | — | — |
| Gross Profit | $482.6M | $461.9M | $242.5M | — | — | $120.9M |
| Operating Income | -$19.7M | $10.5M | -$105.9M | -$67.6M | -$91.8M | -$50.2M |
| Pre-Tax Income | -$17.3M | $11.3M | -$103.8M | -$53.7M | -$77.2M | -$36.0M |
| Income Tax | $745,000 | $3.6M | $2.0M | $5.4M | $5.0M | $2.8M |
| Net Income | -$18.0M | $7.7M | -$105.8M | -$59.1M | -$82.2M | -$38.8M |
| Diluted EPS | -$1.00 | $0.40 | -$5.20 | -$3.40 | -$4.20 | -$0.09 |
Amarin Corp Plcuk Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $49.7M | $49.2M | $45.1M | $42.2M |
| Net Income | -$7.7M | -$1.2M | -$10.5M | -$7.7M |
| Diluted EPS | -$0.02 | -$0.00 | -$0.03 | -$0.02 |
Amarin Corp Plcuk Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $187.0M | $219.5M | $217.7M | $199.3M | $121.0M | $134.7M |
| Current Assets | $879.2M | $878.7M | $689.1M | $725.0M | $595.4M | $649.9M |
| Total Assets | $966.0M | $1.07B | $886.2M | $831.7M | $685.3M | $670.8M |
| Current Liabilities | $307.4M | $370.7M | $259.5M | $259.3M | $179.9M | $194.5M |
| Total Liabilities | $338.5M | $401.0M | $290.8M | $279.6M | $199.2M | $211.5M |
| Shareholders' Equity | $627.5M | $667.1M | $595.3M | $552.1M | $486.2M | $459.3M |
Amarin Corp Plcuk Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | -$21.7M | -$66.5M | -$180.1M | — | — | $6.7M |
| Cash From Investing | -$377.0M | $104.1M | $175.3M | — | — | $8.8M |
| Cash From Financing | -$58.9M | -$5.1M | -$379,000 | — | — | -$2.0M |
| Free Cash Flow | -$22.0M | — | — | $0 | $0 | — |
Figures from Amarin Corp Plcuk's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Amarin Corp Plcuk financials page for every line item.
Amarin Corp Plcuk Company Profile
| Ticker | AMRN |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | Dublin 2 |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0000897448 |
Frequently Asked Questions
What was Amarin Corp Plcuk's revenue in fiscal 2025?
Amarin Corp Plcuk (AMRN) reported revenue of $213.6M for fiscal 2025.
What is Amarin Corp Plcuk's annual revenue history?
Amarin Corp Plcuk's annual revenue by fiscal year: 2020: $614.1M; 2021: $583.2M; 2022: $369.2M; 2023: $285.3M; 2024: $204.6M; 2025: $213.6M.
What was Amarin Corp Plcuk's net income in fiscal 2025?
Amarin Corp Plcuk reported net income of -$38.8M for fiscal 2025.
What was Amarin Corp Plcuk's earnings per share (EPS) in fiscal 2025?
Amarin Corp Plcuk's diluted EPS was -$0.09 for fiscal 2025 (adjusted for any later stock splits).
What was Amarin Corp Plcuk's revenue last quarter?
In its most recent reported quarter (2026 Q2), Amarin Corp Plcuk reported revenue of $42.2M.
How many shares of Amarin Corp Plcuk are outstanding?
Amarin Corp Plcuk reported a weighted average of 416.4 million basic shares outstanding in 2026 Q2.
What is Amarin Corp Plcuk's market cap?
Based on its latest closing price, Amarin Corp Plcuk (AMRN) has a market capitalization of about $241.1M.
When does Amarin Corp Plcuk's fiscal year end?
Amarin Corp Plcuk's fiscal year end, as registered with the SEC, is December 31.
Where is Amarin Corp Plcuk headquartered?
Amarin Corp Plcuk lists its business address in Dublin 2 in its SEC filings.